These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31724259)

  • 1. BRD4 promotes glioma cell stemness via enhancing miR-142-5p-mediated activation of Wnt/β-catenin signaling.
    Wang J; Quan Y; Lv J; Gong S; Dong D
    Environ Toxicol; 2020 Mar; 35(3):368-376. PubMed ID: 31724259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/β-catenin signaling.
    Song H; Shi L; Xu Y; Xu T; Fan R; Cao M; Xu W; Song J
    Eur J Pharmacol; 2019 Jun; 852():189-197. PubMed ID: 30876979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt/β-catenin signaling pathway.
    Tian W; Zhu W; Jiang J
    Cell Biol Int; 2020 May; 44(5):1156-1167. PubMed ID: 32009256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIB3 confers glioma cell stemness via interacting with β-catenin.
    Lu Y; Li L; Chen L; Gao Y; Chen X; Cao Y
    Environ Toxicol; 2020 Jun; 35(6):697-706. PubMed ID: 31995275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-30a-5p is induced by Wnt/β-catenin pathway and promotes glioma cell invasion by repressing NCAM.
    Wang Z; Dai X; Chen Y; Sun C; Zhu Q; Zhao H; Liu G; Huang Q; Lan Q
    Biochem Biophys Res Commun; 2015 Sep; 465(3):374-80. PubMed ID: 26255203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-139/PDE2A-Notch1 feedback circuit represses stemness of gliomas by inhibiting Wnt/β-catenin signaling.
    Li SZ; Ren KX; Zhao J; Wu S; Li J; Zang J; Fei Z; Zhao JL
    Int J Biol Sci; 2021; 17(13):3508-3521. PubMed ID: 34512162
    [No Abstract]   [Full Text] [Related]  

  • 7. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 9. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
    Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
    Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREPT promotes glioma cell proliferation and invasion by activating Wnt/β-catenin pathway and is a novel target of microRNA-596.
    Wei M; Cao Y; Jia D; Zhao H; Zhang L
    Biochimie; 2019 Jul; 162():116-124. PubMed ID: 30995540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes glioma growth.
    Yan Z; Wang J; Wang C; Jiao Y; Qi W; Che S
    FEBS Lett; 2014 Aug; 588(17):3038-46. PubMed ID: 24931370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.
    Fan D; Ren B; Yang X; Liu J; Zhang Z
    J Exp Clin Cancer Res; 2016 Nov; 35(1):177. PubMed ID: 27846906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
    Liu T; Wu X; Chen T; Luo Z; Hu X
    Clin Cancer Res; 2018 Apr; 24(7):1748-1760. PubMed ID: 28972040
    [No Abstract]   [Full Text] [Related]  

  • 17. miR-204-5p promotes the adipogenic differentiation of human adipose-derived mesenchymal stem cells by modulating DVL3 expression and suppressing Wnt/β-catenin signaling.
    He H; Chen K; Wang F; Zhao L; Wan X; Wang L; Mo Z
    Int J Mol Med; 2015 Jun; 35(6):1587-95. PubMed ID: 25847080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/β-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7.
    Yue X; Lan F; Xia T
    Mol Ther; 2019 Nov; 27(11):1939-1949. PubMed ID: 31402274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-138-5p Inhibits Thyroid Cancer Cell Growth and Stemness by Targeting TRPC5/Wnt/β-Catenin Pathway.
    Huang B; Zhang Y; Sun P; Yuan Y; Wang C
    Mol Biotechnol; 2024 Mar; 66(3):544-553. PubMed ID: 37278959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.
    Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y
    Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.